Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pal Czobor

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|April 22, 2015
Pharmacological treatment of negative symptoms in schizophreniaHans-Jürgen Möller, Pal Czobor
Journal of Clinical Psychopharmacology|June 4, 2010
A prospective longitudinal study of cholesterol and aggression in patients randomized to clozapine, olanzapine, and haloperidolMenahem I Krakowski, Pal Czobor
Schizophrenia Research|September 27, 2012
The denial of aggression in violent patients with schizophreniaMenahem I Krakowski, Pal Czobor
Schizophrenia Research|March 10, 2009
Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidolMenahem Krakowski, Pal Czobor, Leslie Citrome
Expert Opinion on Drug Safety|May 7, 2011
Adverse reactions to duloxetine in depressionIstvan Bitter, Dora Filipovits, Pal Czobor
Journal of Psychiatric Research|May 2, 2022
Separate pathways to violent behavior in schizophrenia and in the general populationMenahem I Krakowski, Umit Tural, Pal Czobor
Journal of Psychiatric Research|November 13, 2024
Dysfunctional activation of the default mode network in response inhibition in schizophreniaMenahem Krakowski, Matthew J Hoptman, Pal Czobor
European Psychiatry : the Journal of the Association of European Psychiatrists|August 9, 2005
Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO)Istvan Bitter, Pal Czobor, Martin Dossenbach, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 13, 2024
The importance of incorporation of real-world evidence into the guidelines on the pharmacological treatment of schizophreniaIstvan Bitter, Lajos Katona, Peter Falkai, et al.
Psychiatria Hungarica : a Magyar Pszichiatriai Tarsasag Tudomanyos Folyoirata|November 5, 2021
Behaviour and Experience: The Two Sides of the Negative Syndrome - A Comparison of Andreasen's Negative Syndrome and Huber's Basic SymptomsIsvtvan Bitter, Judith Jaeger, Jan Volavka, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
European Archives of Psychiatry and Clinical Neuroscience|April 22, 2015
Pharmacological treatment of negative symptoms in schizophreniaHans-Jürgen Möller, Pal Czobor
Journal of Clinical Psychopharmacology|June 4, 2010
A prospective longitudinal study of cholesterol and aggression in patients randomized to clozapine, olanzapine, and haloperidolMenahem I Krakowski, Pal Czobor
Schizophrenia Research|September 27, 2012
The denial of aggression in violent patients with schizophreniaMenahem I Krakowski, Pal Czobor
Schizophrenia Research|March 10, 2009
Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidolMenahem Krakowski, Pal Czobor, Leslie Citrome
Expert Opinion on Drug Safety|May 7, 2011
Adverse reactions to duloxetine in depressionIstvan Bitter, Dora Filipovits, Pal Czobor
Journal of Psychiatric Research|May 2, 2022
Separate pathways to violent behavior in schizophrenia and in the general populationMenahem I Krakowski, Umit Tural, Pal Czobor
Journal of Psychiatric Research|November 13, 2024
Dysfunctional activation of the default mode network in response inhibition in schizophreniaMenahem Krakowski, Matthew J Hoptman, Pal Czobor
European Psychiatry : the Journal of the Association of European Psychiatrists|August 9, 2005
Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO)Istvan Bitter, Pal Czobor, Martin Dossenbach, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 13, 2024
The importance of incorporation of real-world evidence into the guidelines on the pharmacological treatment of schizophreniaIstvan Bitter, Lajos Katona, Peter Falkai, et al.
Psychiatria Hungarica : a Magyar Pszichiatriai Tarsasag Tudomanyos Folyoirata|November 5, 2021
Behaviour and Experience: The Two Sides of the Negative Syndrome - A Comparison of Andreasen's Negative Syndrome and Huber's Basic SymptomsIsvtvan Bitter, Judith Jaeger, Jan Volavka, et al.
Pageof 6